- Clinigen 305.25 0.00
- Fusion Ip 60.00 0.00
- Fitbug 0.93 0.00
- Go-ahead Group 1,429.00 0.00
- Leni Gas 0.98 0.00
- Puricore 39.00 0.00
- Silverdell 13.75 0.00
- Tri-star Res. 0.28 0.00
- Ubc Media 2.13 0.00
- Unilever 2,674.00 0.00
Broker News & Views
Thursday, 26th April 2012
Espirito Santo Execution Noble initiates buy on Laird, target price 280p. Numis downgrades Whitbread from buy to add, target price unchanged at 2,100p.S&P Equity Research upgrades Serco from buy to strong buy, target price increased from 587p to 671p.
Alphavalue downgrades Dixons Retail from buy to add, target price increased from 21.2p to 21.3p.
Morgan Stanley upgrades Carphone Warehouse from underweight to equalweight, target price unchanged at 125p.
Seymour Pierce initiates buy on Monitise, target price 55p.
Merchant Securities downgrades Character Group from buy to hold, target price is cut from 202p to 170p.
Seymour Pierce downgrades Berensden from buy to add, target price unchanged at 545p.
Numis upgrades Elementis from hold to add, target price unchanged at 222p.
Peel Hunt upgrades Rotork from sell to hold, target price increased from 1980p to 2100p.
At 2:23pm:
(LON:CPW) Carphone Warehouse share price was +1.38p at 127.38p
(LON:DXNS) Dixons Group share price was -0.13p at 18.08p
(LON:LARD) Laird Group share price was -0.25p at 531.75p
(LON:SRP) Serco Group share price was -4.5p at 540.5p
(LON:WTB) Whitbread share price was +77p at 1886p
Story provided by StockMarketWire.com
Stock Market Update
Thursday, 20th June 2013
PRE-OPEN REPORT: The headline index is tipped to open with triple-digit losses, according to financial ...
Share News
Thursday, 20th June 2013
Clinigen Clinical Trial Supply has extended its exclusive clinical trial distribution agreement with Accord ...
Thursday, 20th June 2013
The CBI responded to the final report from the Parliamentary Commission on Banking Standards. John Cridland, ...
Thursday, 20th June 2013
PuriCore has signed a sales agreement for its new ProduceFresh bottled concentrate valued at about ...
Thursday, 20th June 2013
Fusion IP portfolio company Diurnal has received approval for a 'paediatric investigation plan' from the ...
SharePrice.com will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. All share prices are provided by the London Stock Exchange, and are at least 15 minutes delayed.